Wolf Theiss

Wolf Theiss advises Takeda Group with its Acquisition of Plasmapunkt Favoriten and Donaustadt

Vienna, 16 April 2019 – Wolf Theiss has advised the Takeda Group with its acquisition of the plasma donation center Plasmapunkt Favoriten and Donaustadt. The signing took place on 3 April.

Wolf Theiss advised the Takeda Group with structuring of the transaction, legal due diligence, tax due diligence, negotiation of the transaction and drafting of all transaction documents.

Under the lead of Partner Sarah Wared (M&A/Corporate), Associates Clemens Pretscher, Michael Kienzl, Simona Shpilsky (all Corporate), Partner Niklas Schmidt & Counsel Eva Stadler (both Tax), Senior Associate Paulina Pomorski & Partner Roland Marko (both IP/IT), Senior Associate Georg Harer, Associate Vilma-Reeta Kivilahti (all Banking & Finance) & Partner Kurt Retter and Associate Dominik Engel (both Regulatory), Associate Valentina Riedler & Counsel Walter Pöschl (both Employment), Associate Iris Riepan & Partner Karl Binder (both Real Estate & Construction) worked on this transaction.

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing better health to people worldwide. The passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.


For further information please contact

Barbara Fürchtegott
Public Relations & Communications Manager
T. +43 1 51510 3808
Schubertring 6
1010 Vienna

Find a Lawyer